Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients.
Julie C RefardtTessa BrabanderNoémie S MinczelesRichard A FeeldersWouter W de HerderJohannes HoflandPublished in: European journal of endocrinology (2022)
The occurrence of hypo- or hypernatremia in PRRT-treated NET patients is associated with opposing outcomes with regard to overall survival. Sodium levels might have a prognostic role in these patients.